Initiative aims to foster collaborations and move basic research into the clinic.

Eight collaborative nanomedicine projects have been selected out of 33 applications to receive €8 million (about $11.2 million) in funding under the European Commission’s EuroNanoMed funding initiative.

The latest tranche of EuroNanMed cash has been allocated following a 2nd joint transnational call for collaborative research, focused on nanmedicine-related diagnostics, targeted delivery systems and regenerative medicine. The eight successful projects will involve 46 partners from 10 countries, and span all three research areas.

The EuroNanoMed initiative has been established under the EC’s ERA-Net program, which aims to advance transnational research in nanomedicine by fostering collaborative and multidisciplinary research and technology development (RTD) projects to help speed the translation of research into clinical practice. Participants include scientists and research groups in academia, clinical/public health communities and industry (particularly small and medium-sized enterprises).

The EuroNanoMed consortium  includes 24 partners (ministries and agencies) from 15 countries and three regions. The total budget dedicated to the EuroNanoMed calls for proposals represents about 15% to 20% of the sum of the national/regional budgets allocated to nanomedicine applications. After the success of the first two calls, a 3rd joint transnational call for research projects is planned for launch in January 2011.

Previous articleProtein Sciences Expands Flu Vaccine Candidate License Arrangement with UMN
Next articleAntisoma and Novartis Ditch ASA404 After Second Phase III NSCLC Trial Bombs